Loading clinical trials...
Loading clinical trials...
Comparison Between Vonoprazan-Based Triple Therapy and Esomeprazole-Based Triple Therapy for Eradication of Helicobacter Pylori Infection: An Open-Label Randomized Controlled Trial
Conditions
Interventions
vonoprazan-based triple therapy (VAL regimen)
Esomeprazole-based triple therapy (EAL regimen)
Locations
2
Bangladesh
Bangabandhu Sheikh Mujib Medical University
Dhaka, Bangladesh
Bangabandhu Sheikh Mujib Medical University
Dhaka, Bangladesh
Start Date
April 15, 2026
Primary Completion Date
August 14, 2026
Completion Date
August 14, 2026
Last Updated
April 22, 2026
NCT07516262
NCT07335406
NCT07179159
NCT07442734
NCT07293910
NCT05880199
Lead Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions